Literature DB >> 31270028

miR-454-3p promotes proliferation and induces apoptosis in human cervical cancer cells by targeting TRIM3.

Yu Song1, Qisang Guo1, Shujun Gao2, Keqin Hua3.   

Abstract

Abnormally expressed microRNAs have been demonstrated related to the development and progression of cervical cancer. However, the molecular mechanisms remain largely unkown. Here, we aimed to demonstrate the exact role of miR-454-3p in cervical cancer. Depletion of miR-454-3p in cervical cancer cells resulted in inhibition of cell growth and promotion of cell apoptosis. Bioinformatics analysis predicted that tripartite motif-containing 3 (TRIM3), a tumor suppressor gene in cervical cancer, is a promising target of miR-454-3p. Dual-luciferase reporter gene assay revealed that miR-454-3p directly target TIRM3 by binding to the 3'UTR of TIRM3. In cervical cancer cells (C-33A and SiHa) with endogenous low TRIM3 expression, decreased expression of miR-454-3p significantly elevated TRIM3 expression. In the cervical cancer cell (HeLa) with endogenous high TRIM3 expression, increased expression of miR-454-3p obviously inhibited TRIM3 expression and then manipulating cell growth and apoptosis, down-regulating the expression of P53 and cleaved caspase-3 via P38 MAPK signaling. Taken together, these findings demonstrated miR-454-3p as a cancer promoter by targeting TRIM3 in human cervical cancer.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cervical cancer; Hsa-miR-454-3p; TRIM3; Tumor promoter

Year:  2019        PMID: 31270028     DOI: 10.1016/j.bbrc.2019.06.126

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  15 in total

Review 1.  Cervical cancer development, chemoresistance, and therapy: a snapshot of involvement of microRNA.

Authors:  Tandrima Mitra; Selvakumar Elangovan
Journal:  Mol Cell Biochem       Date:  2021-08-28       Impact factor: 3.396

2.  Tumor Suppressor 4.1N/EPB41L1 is Epigenetic Silenced by Promoter Methylation and MiR-454-3p in NSCLC.

Authors:  Qin Yang; Lin Zhu; Mao Ye; Bin Zhang; Peihe Zhan; Hui Li; Wen Zou; Jing Liu
Journal:  Front Genet       Date:  2022-06-20       Impact factor: 4.772

3.  Ultrasound-targeted microbubble destruction-mediated miR-767 inhibition suppresses tumor progression of non-small cell lung cancer.

Authors:  Xiaohua Li; Min Xu; Wenyu Lv; Xingwang Yang
Journal:  Exp Ther Med       Date:  2020-03-12       Impact factor: 2.447

4.  MiR-873, as a suppressor in cervical cancer, inhibits cells proliferation, invasion and migration via negatively regulating ULBP2.

Authors:  Hai-Xia Liang; Yu-Hong Li
Journal:  Genes Genomics       Date:  2020-01-04       Impact factor: 1.839

Review 5.  Research progress on exosomal proteins as diagnostic markers of gastric cancer (review article).

Authors:  Hang Su; Weihong Ren; Dai Zhang
Journal:  Clin Exp Med       Date:  2022-01-22       Impact factor: 3.984

6.  CircGDI2 Regulates the Proliferation, Migration, Invasion and Apoptosis of OSCC via miR-454-3p/FOXF2 Axis.

Authors:  Dan Shi; Huiyun Li; Junge Zhang; Yadong Li
Journal:  Cancer Manag Res       Date:  2021-02-11       Impact factor: 3.989

7.  miR-454-3p prevents ox-LDL-induced apoptosis in HAECs by targeting TRPC3.

Authors:  Luming Liao; Qiaolan Yang; Hailiang Li; Rongsen Meng; Yuntian Li
Journal:  Exp Ther Med       Date:  2021-02-05       Impact factor: 2.447

8.  Construction and Comparison of ceRNA Regulatory Network for Different Age Female Breast Cancer.

Authors:  Zhi-Qin Liu; Gao-Tao Zhang; Li Jiang; Chun-Qing Li; Que-Ting Chen; Du-Qiang Luo
Journal:  Front Genet       Date:  2021-04-21       Impact factor: 4.599

9.  miR‑454‑3p inhibits non‑small cell lung cancer cell proliferation and metastasis by targeting TGFB2.

Authors:  Hongliang Liao; Yaqin Liang; Lin Kang; Yun Xiao; Tao Yu; Renping Wan
Journal:  Oncol Rep       Date:  2021-03-24       Impact factor: 3.906

10.  HAND2-AS1 inhibits invasion and metastasis of cervical cancer cells via microRNA-330-5p-mediated LDOC1.

Authors:  Shengcai Chen; Jing Wang
Journal:  Cancer Cell Int       Date:  2019-12-27       Impact factor: 5.722

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.